• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 11 of 100
Google DeepMind director of strategic initiatives, Terra Terwilliger, speaking onstage at Fortune's COO Summit.
TechGoogle DeepMind exec says AI will increase efficiency so much it’s expected to handle 50% of info requests in its legal department
By Paolo ConfinoOctober 7, 2024
Albert Bourla puts his palm flat on tup of his other hand, rolled up in a fist, as he sits and listens to a question onstage at a conference.
FinancePfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
By Greg McKennaOctober 7, 2024
balding head
HealthHair loss drug probed in Europe over link to suicidal thoughts
By Ashleigh Furlong and BloombergOctober 4, 2024
woman sitting in the dark looking at a light-therapy box
MindBright light therapy used for Seasonal Affective Disorder can help treat other depressions too
By Beth GreenfieldOctober 2, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company's headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023.
HealthNovo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders
By Ryan HoggSeptember 24, 2024
FinanceNovo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
By Sara Sjolin, Sanne Wass, Oliver Crook and BloombergSeptember 23, 2024
COVID-19 symptoms can be mild, severe, or nonexistent, according to the Centers for Disease Control and Prevention—and can appear as late as two weeks after you’ve been exposed to the virus.
HealthCould it be COVID? Here are the symptoms to watch out for in 2024
By Lindsey LeakeSeptember 21, 2024
LeadershipMark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could
By Sydney LakeSeptember 16, 2024
NewslettersEli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
By Sheryl EstradaSeptember 10, 2024
CommentaryAging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it
By Alex ZhavoronkovSeptember 9, 2024
LeadershipThe Fortune 500 is built on more than money. It’s built on human, social, and natural capital, too
By Andre Hoffmann and Peter VanhamSeptember 6, 2024
TechHalf of Denmark’s GDP growth in 2024 will be thanks to Novo Nordisk, analysts predict
By Sanne Wass and BloombergSeptember 3, 2024
Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s Spikevax vaccines early.
HealthNew COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By Lindsey LeakeAugust 29, 2024
CommentaryBig Tech wants to keep stealing patents—so it’s going to war with Big Pharma
By Andrei Iancu and David J. KapposAugust 28, 2024
FinanceNovo Nordisk’s weight-loss drugs and Bavarian Nordic’s mpox vaccine help fatten up the Danish economy
By Sanne Wass and BloombergAugust 20, 2024
1...
  • 9
  • 10
  • 11
  • 12
  • 13
...100
Most Popular
Personal Finance
The national debt isn't $39 trillion. One economist says it's actually $100 trillionAn image of a popular article
By Nick LichtenbergMarch 13, 2026
Economy
'This cannot be sustainable': The U.S. borrowed $50 billion a week for the past five months, the CBO saysAn image of a popular article
By Eleanor PringleMarch 10, 2026
North America
The U.S. Mint dropped the olive branch from the dime. What does that mean for the country?An image of a popular article
By Catherina GioinoMarch 12, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.